% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • terminator2089 terminator2089 Nov 11, 2013 5:44 PM Flag

    Price Movement

    The price movement makes little logical sense. CUDC 427 is in phase I clinical studies and is probably 5-7 years, or even longer away from ever reaching the market. The value of the phase I data either positive or negative simply isn't relative to the current PPS. The PPS should be primarily due to Erivedge sales. Even if the CUDC 427 phase I trials were positive at this point it wouldn't warrant a significant price increase. The price move is nonsense here IMHO. Its a strong buy here at this point. I also doubt the FDA trial death was even related to the study medication

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.75+0.15(+5.77%)Nov 25 3:59 PMEST